Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.

Topical latanoprost doesn't effectively regrow hair in severe eyebrow alopecia areata cases.

Men with more vanadium in their blood and who drink less soy milk are more likely to have hair loss.

Patterned hair loss is relatively common in women and not usually a sign of serious health issues.

A man had temporary hair loss from radiation during a medical procedure but regrew his hair after treatment with minoxidil lotion.

Dutasteride mesotherapy showed mixed results and is not recommended as a primary treatment for hair loss.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

Oxidative stress plays a significant role in alopecia areata, and new treatments may include JAK inhibitors and antioxidants.

Topical immunotherapy is the best treatment for severe alopecia areata.

Adalimumab was safe but mostly ineffective for severe alopecia areata.

Proper diagnosis and treatment of childhood hair loss require distinguishing between alopecia and trichotillomania.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Using growth factors and microneedling shows promise for hair regrowth in Alopecia Areata, but more research is needed.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Different scalp and hair disorders are more common in certain ethnic groups, with the most common being androgenetic alopecia, which is treated with medications like minoxidil and finasteride.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Topical sensitizers have mixed success in treating alopecia areata.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

Corticosteroid pulse therapy is more effective for severe alopecia areata than combination therapy.

The nanoemulsion with garlic oil, apple cider vinegar, and minoxidil could effectively treat alopecia areata.

Both platelet-rich plasma and low-level laser therapy effectively treat hair loss with minimal side effects and good cost-benefit ratio.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Intralesional triamcinolone acetonide is more effective but has a higher relapse rate than platelet-rich plasma for treating alopecia areata.

HSP90 and lamin A/C are crucial for hair growth and could be targets for treating hair loss.